3rd Quarter - Report

FORBES-TATE for ALEXION PHARMACEUTICALS, INC.

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to healthcare, including drug pricing and Medicare Part D; Issues related to low-volume Diagnosis Related Groups (DRG); Issues related to orphan drug tax credit and issues related to rare disease; Issues Related to to H.R. 5376 - Inflation Reduction Act of 2022 (P.L. 117-169).

LobbyistCovered position, as disclosed
CYNTHIA BROWN —
JERRY DRISCOLL —
JEFFREY FORBES —
ELIZABETH GREER —
JEFFREY SADOSKY —
DERRICK M WHITE —
ZACHARY WILLIAMS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 5376 (117th)

Medicare/Medicaid MMM

Issues related to healthcare, including drug pricing and Medicare Part D; Issues Related to H.R. 5376 - Inflation Reduction Act of 2022 (P.L. 117-169).

LobbyistCovered position, as disclosed
CYNTHIA BROWN —
JERRY DRISCOLL —
JEFFREY FORBES —
ELIZABETH GREER —
JEFFREY SADOSKY —
DERRICK M WHITE —
ZACHARY WILLIAMS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 5376 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.